Structure of two G-quadruplexes in equilibrium in the KRAS promoter

Julien Marquevielle1, Coralie Robert1, Olivier Lagrabette1

  • 1European Institute of Chemistry and Biology (IECB), ARNA laboratory, INSERM U1212 - CNRS UMR 5320, University of Bordeaux, France.

Insights

Researchers explored KRAS G-quadruplexes (G4) as a novel therapeutic target. They identified two stable conformations of the KRAS 32R sequence, revealing key nucleotides involved in their structural exchange.

Area of Science:

  • Molecular Biology
  • Biophysics
  • Genetics

Background:

  • KRAS is a frequently mutated oncogene, posing a significant challenge in cancer therapy.
  • Targeting KRAS directly has proven difficult, necessitating alternative strategies like targeting its gene.
  • G-quadruplexes (G4) are G-rich secondary DNA structures with roles in biological processes and are potential therapeutic targets.

Purpose of the Study:

  • To investigate the structural conformations of the KRAS 32R sequence, a G-rich region within the KRAS promoter.
  • To understand the dynamic equilibrium between different G4 structures formed by the KRAS 32R sequence.
  • To identify key nucleotides and structural motifs involved in G4 formation and stability within the KRAS gene.

Main Methods:

  • Biophysical techniques were employed to study the KRAS 32R sequence.
  • Structural analysis focused on identifying the major stable conformers of the G4 structure.
  • Equilibrium dynamics between conformations were investigated using kinetic studies.

Main Results:

  • Two major stable conformations of the KRAS 32R G-quadruplex were identified.
  • A slow equilibrium (>ms) was observed between these two distinct conformations.
  • Specific nucleotides (G9, G25, G28, G32) were found to be crucial for the conformational exchange.
  • A 3' terminal triad significantly stabilized one G4 conformer, while the other remained more flexible.

Conclusions:

  • The KRAS 32R sequence can adopt distinct G4 structures with differing stability and dynamics.
  • Understanding these conformations and their interconversion is vital for developing G4-targeting therapies for KRAS-driven cancers.
  • The identified structural features provide insights for designing small molecules to selectively target specific KRAS G4 conformations.

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.5K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.0K